Stonegate Updates Coverage on SES AI Corp. (SES) 2Q26
SES AI Corp. (NYSE: SES) received an updated 2Q26 coverage note from Stonegate Capital Partners indicating that commercialization progress improved even as sequential revenue declined and the quarter modestly missed headline expectations.
Rhea-AI Summary
SES AI Corp. (NYSE: SES) received an updated 2Q26 coverage note from Stonegate Capital Partners indicating that commercialization progress improved even as sequential revenue declined and the quarter modestly missed headline expectations. All four product lines generated revenue, including ESS, drones, materials, and Molecular Universe.
Stonegate highlighted Sol-Ark certification as materially expanding UZ Energy’s U.S. energy storage systems opportunity from late 2026 into 2027. Drone demand is described as the strongest near-term growth driver, with SES scaling NDAA-compliant capacity to 1 million cells annually versus about 700,000–800,000 deliverable capacity and roughly 1.5 million potential annual cells from five large drone prospects. SES reaffirmed FY26 guidance of $30–$35 million in revenue and roughly 15% gross margin, implying $18.2–$23.2 million of 2H26 revenue.
Positive
- All four SES product lines generated revenue in 2Q26
- Sol-Ark certification expands UZ Energy’s U.S. ESS opportunity from late 2026
- Drone pipeline from ~five prospects totals ~1.5M potential annual cells
- SES is scaling NDAA-compliant production to 1M cells annually
- FY26 guidance reaffirmed at $30M–$35M revenue and ~15% gross margin
- Implied 2H26 revenue ramp of $18.2M–$23.2M
Negative
- 2Q26 delivered lower sequential revenue
- Quarter featured a modest headline miss versus expectations
- Current deliverable capacity only ~700K–800K cells vs ~1.5M potential demand
- FY26 guidance requires a sizable 2H26 ramp to achieve $30M–$35M revenue
Details
News Market Reaction – SES
On Aug 13, the first trading day after this news, SES closed 7.48% above the previous close. Argus tracked a peak move of +14.1% during that session. Argus tracked a trough of -7.4% from its starting point during tracking. Our momentum scanner recorded 60 alerts for this stock that day. Relative volume reached 3.5x the daily average during tracking.
Data tracked by StockTitan Argus for the Aug 13 session.
Key Figures
- Product lines with revenue
- 4 product lines
- 2Q26
- NDAA-compliant capacity
- 1M cells annually
- Drone pipeline
- Large prospects
- ~five prospects
- Potential drone customers
- Potential annual cells
- ~1.5M cells
- Large drone prospects
- Deliverable capacity
- ~700K-800K cells
- Current capacity
- FY26 revenue guidance
- $30M-$35M
- Reaffirmed FY26 guidance
- Gross margin guidance
- ~15%
- FY26 guidance
- 2H26 revenue implication
- $18.2M-$23.2M
- Implied by FY26 guidance
Previous AI Reports
-
Doroni framework agreement supported battery-pack development and potential production expansion.
-
NYSE cited noncompliance after the average share price remained below $1.00.
-
SES AI joined the Russell 3000 Index, increasing institutional investor visibility.
-
Yi Liu succeeded Jing Nealis as chief financial officer effective April 27.
-
SES projected Q1 revenue above consensus and reaffirmed full-year guidance.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
ndaa-compliant regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
Dallas, Texas--(Newsfile Corp. - August 12, 2026) - SES AI Corp. (NYSE: SES): Stonegate Capital Partners Updates Coverage on SES AI Corp. (NYSE: SES). SES' 2Q26 update improves the commercialization setup despite lower sequential revenue, as the quarter provided clearer evidence that the company's broader commercial strategy is beginning to take hold. The headline miss was modest, but the underlying read-through was better: all four product lines contributed, Sol-Ark certification expands UZ Energy's U.S. ESS opportunity, and the NDAA drone pipeline suggests capacity - not just qualification - could become a constraint as customers convert to orders. FY26 guidance was unchanged, leaving a sizable 2H ramp to execute, but the path is becoming clearer over coming quarters across ESS, drones, materials, and Molecular Universe.
To view the full announcement, including downloadable images, bios, and more, click here.
Key Takeaways:
- Commercialization is broadening across the portfolio. All four product lines generated revenue, while Sol-Ark certification materially expands UZ Energy's U.S. ESS opportunity and supports a larger contribution beginning later in 2026 and into 2027.
- Drone demand is emerging as the strongest near-term growth driver. SES is scaling NDAA-compliant capacity to 1M cells annually, while ~five large prospects alone represent ~1.5M potential annual cells versus only ~700K-800K of deliverable capacity.
- FY26 guidance remains achievable but requires a meaningful 2H ramp. SES reaffirmed
$30M -$35M of revenue and ~15% gross margin, implying$18.2M -$23.2M in 2H26, supported by ESS growth and increasing drone/materials contributions.
Click image above to view full announcement.
About Stonegate
Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies.
Contacts:
Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com
Source: Stonegate, Inc.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/309430
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
